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Research
The association between air pollution and 
cardio  vascular morbidity and mortality is 
supported by epidemiologic and experimen-
tal evidence (Bhatnagar 2006; Brook et al. 
2004; Delfino et al. 2005; Dockery et al. 
1993; Dominici et al. 2006; Donaldson et al. 
2001; Petrovic et al. 2000; Samet et al. 2000; 
Schwartz 1999). Systemic inflammation may 
be one of the potential mechanisms mediat-
ing the effect of air pollution on cardiovas-
cular outcomes (Pekkanen et al. 2000; Peters 
et al. 1997, 2001a, 2001b; Rückerl et al. 2007; 
Schwartz 2001; Seaton et al. 1999).
Elevated systemic levels of interleukin-6 
(IL-6) have been demonstrated to be an 
independent risk factor for cardiovascular 
morbidity and mortality (Cesari et al. 2003; 
Volpato et al. 2001). IL-6 also stimulates the 
production of acute-phase proteins, including 
C-reactive protein (CRP), which can pre-
dict cardiovascular risk (Ridker et al. 2000). 
The literature documents pollutant-associated 
elevations in pulmonary IL-6 in healthy sub-
jects (in vivo) and tissue (in vitro) and pollut-
ant-associated elevations in systemic IL-6 in 
subjects with preexisting chronic inflamma-
tory conditions (Arsalane et al. 1995; Carter 
et al. 1997; Devlin et al. 1991; Dubowsky 
et al. 2006; Nordenhäll et al. 2000; Quay 
et al. 1998; Rückerl et al. 2006), although 
this association has not been demonstrated in 
young, healthy subjects.
Similar to IL-6, elevated levels of fibrino-
gen have been shown to be an independent risk 
factor for cardiovascular disease (Fibrinogen 
Studies Collaboration 2005; Kannel et al. 
1987) and have also been hypothesized to be 
associated with air pollution (Chuang et al. 
2007; Pekkanen et al. 2000; Rückerl et al. 
2007; Seaton et al. 1999; Steinvil et al. 2008). 
This hypothesis is supported by literature 
considering air pollution and disturbances in 
hemostasis in general (Baccarelli et al. 2007, 
2008; Nemmar et al. 2006), although studies 
considering the specific association between 
air pollutants and fibrinogen report conflicting 
results (Chuang et al. 2007; Pekkanen et al. 
2000; Rückerl et al. 2007; Seaton et al. 1999; 
Steinvil et al. 2008).
Human exposure studies aim to deter-
mine the biological effects of air pollutants by 
using controlled levels of pollutants coupled 
with an extensive exposure characterization 
and detailed measurements of physiologic 
outcomes. For example, controlled human 
exposure studies using fine concentrated 
ambient particles (CAPs) have demonstrated 
changes in biomarkers associated with sys-
temic inflammation, including IL-6 and 
fibrinogen (Gong et al. 2003, 2004, 2008; 
Petrovic et al. 2000).
In this study we investigated the asso-
ciation between ambient air pollution and 
inflammatory markers using baseline data 
from chamber study exposures. We con-
sidered the effects of ozone, nitrogen diox-
ide, sulfur dioxide, and particulate matter 
≤ 2.5 µm in aerodynamic diameter (PM2.5) 
on IL-6 and fibrinogen, using single-pollutant 
models to analyze repeated-measures data in a 
group of healthy subjects. We investigated the 
temporal association between exposure to the 
pollutants and changes in IL-6 and fibrinogen 
using moving averages up to 7 days.
In addition to addressing the question 
of what effect, if any, ambient air pollution 
exposure has on the baseline levels of IL-6 
and fibrinogen, the findings of this study may 
have additional relevance to the interpretation 
of human chamber exposure studies: If ambi-
ent pollution exposure significantly effects 
subjects’ baseline inflammatory markers, then 
pollutant exposure before controlled human 
exposure studies including CAPs may mod-
ify subjects’ inflammatory responses. Before 
investigating possible effect modification 
by ambient pollution exposure on human 
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in t r o d u c t i o n: Systemic inflammation may be one of the mechanisms mediating the association 
between ambient air pollution and cardiovascular morbidity and mortality. Interleukin-6 (IL-6) and 
fibrinogen are biomarkers of systemic inflammation that are independent risk factors for cardio-
vascular disease.
oB j e c t i v e: We investigated the association between ambient air pollution and systemic inflamma-
tion using baseline measurements of IL-6 and fibrinogen from controlled human exposure studies.
Me t h o d s : In this retrospective analysis we used repeated-measures data in 45 nonsmoking sub-
jects. Hourly and daily moving averages were calculated for ozone, nitrogen dioxide, sulfur dioxide, 
and particulate matter ≤ 2.5 µm in aerodynamic diameter (PM2.5). Linear mixed-model regression 
determined the effects of the pollutants on systemic IL-6 and fibrinogen. Effect modification by 
season was considered.
re s u l t s: We observed a positive association between IL-6 and O3 [0.31 SD per O3 interquartile 
range (IQR); 95% confidence interval (CI), 0.08–0.54] and between IL-6 and SO2 (0.25 SD per 
SO2 IQR; 95% CI, 0.06–0.43). We observed the strongest effects using 4-day moving averages. 
Responses to pollutants varied by season and tended to be higher in the summer, particularly for O3 
and PM2.5. Fibrinogen was not associated with pollution.
co n c l u s i o n s: This study demonstrates a significant association between ambient pollutant lev-
els and baseline levels of systemic IL-6. These findings have potential implications for controlled 
human exposure studies. Future research should consider whether ambient pollution exposure 
before chamber exposure modifies IL-6 response.
key w o r d s : air pollution, epidemiology, fibrinogen, inflammation, interleukin-6. Environ Health 
Perspect 118:120–124 (2010).  doi:10.1289/ehp.0900550 available via http://dx.doi.org/ [Online 
29 September 2009] Ambient air pollution and systemic inflammation
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chamber exposure study outcomes, it is first 
necessary to address what effect, if any, ambi-
ent pollution exposure has on subjects’ base-
line inflammatory markers, and this was the 
primary goal of this study.
Materials and Methods
Study population. The study population con-
sisted of 45 adults 18–40 years of age who par-
ticipated in one of two studies conducted in 
Toronto, Ontario, Canada, between 14 July 
1999 and 25 February 2003 (study A) and 
between 8 January 2004 and 27 March 2006 
(study B) and who had IL-6 and fibrinogen 
measurements at baseline before human cham-
ber exposure to air pollution. Exclusion criteria 
common to both studies were based on clini-
cal situations or drugs that had the potential 
to alter systemic inflammation and vascular 
reactivity. Subjects were excluded if they had 
a history of coronary artery disease, previous 
myocardial infarction, peripheral vascular dis-
ease, angina, heart failure, or atherosclerosis 
or used any medications associated with car-
diovascular disorders. For the asthmatic par-
ticipants (n = 10), additional exclusion criteria 
were a forced vital capacity or forced expiratory 
volume in 1 sec of < 75% of the predicted nor-
mal value, or use of oral medications or inhaled 
corticosteroids for asthma. Bronchodilators 
were withheld from midnight before each visit. 
Subjects were also requested to refrain from 
taking any vitamins or over-the-counter prepa-
rations in the 48 hr before each visit.
Study design. We conducted a retrospective 
analysis using repeated-measures data collected 
as part of two controlled human exposure 
investigations. The data used in this study 
consisted of the baseline measurements taken 
before subjects entered the exposure chamber. 
Height and weight measurements were taken 
during the initial visit. Blood draws were con-
ducted at 1000 hours on the day of each visit 
for all participants. All visits were in random 
order and separated by at least 2 weeks.
This study was approved by the St. 
Michael’s Hospital Research Ethics Board. The 
studies from which data were derived complied 
with relevant research ethics guidelines as well 
as the Ontario Personal Health Information 
Act (Personal Health Information Act 2004). 
Human participants gave written informed 
consent before enrollment in the study.
Blood analyses. Venous blood was col-
lected in EDTA tubes for IL-6 and sodium 
citrate tubes for fibrinogen. Samples were 
centrifuged, and the resulting plasma 
samples were stored at –70°C until analy-
sis. Depending on the study for which the 
sample was drawn, samples were analyzed 
for IL-6 using either commercial high- 
sensitivity enzyme-linked immuno  sorbent 
assay (ELISA; Amersham Pharmacia, 
Little Chalfont, Buckinghamshire, UK) or 
the multiplex Luminex bead assay method 
(Luminex, Austin, TX, USA). Fibrinogen 
concentration was determined quantitatively 
based on the Clauss clotting method (MLA 
1600; Medical Laboratory Automation, 
Pleasantville, NY, USA).
Exposure measurements. Hourly ambient 
pollutant data (O3, NO2, SO2, and PM2.5) 
were obtained from an Ontario Ministry of 
the Environment fixed-site air-monitoring 
station located in downtown Toronto. Hourly 
temperature and humidity data, collected at a 
fixed-site air-monitoring station at Pearson 
International Airport in Toronto, were pro-
vided by Environment Canada.
Statistical analysis. We conducted uni-
variate explorations for all variables using 
histograms, linear graphing techniques, and 
summary statistics. We calculated Spearman 
correlation coefficients for the pollutant and 
meteorologic data to investigate the relation-
ships among these variables over the study 
period. The associations between the inflam-
matory markers, IL-6 and fibrinogen, and the 
pollutants, O3, NO2, SO2, and PM2.5, were 
analyzed using linear mixed-effects models 
with random patient intercepts to account 
for repeated measures. Date, day of the week, 
season, and 24-hr moving averages for rela-
tive humidity and temperature were included 
in the models as time-varying confounders 
based on goodness-of-fit as determined using 
Akaike’s information criterion. Age, sex, body 
mass index (BMI), and asthmatic status were 
included as time-invariant participant charac-
teristics associated with the mean levels of the 
inflammatory markers to permit the assump-
tion of a normally distributed random patient 
intercept. Age and date were included in the 
models as linear variables. We considered data 
for each of the pollutants at the time of blood 
draw (baseline) along with the 2-, 4-, 6-, and 
12-hr and 1- to 7-day moving averages of the 
pollutants. We assessed effect modification 
using an interaction term in the models while 
also including the main effects of season and 
pollution. The interaction term consisted of 
a four-level categorical term for season multi-
plied by the pollutant being analyzed.
IL-6 data from each study were not 
directly comparable because study A analyzed 
samples using ELISA plates whereas study 
B used the Luminex bead assay system. To 
allow compilation of the IL-6 data into a 
single data set, the data were transformed to 
standard scores (Z-scores). As a result, effect 
estimates for IL-6 are presented as the linear 
change in the SD of IL-6 per each pollutant’s 
interquartile range (IQR). Fibrinogen levels 
were measured using the same techniques in 
both studies, so effect estimates for fibrino-
gen are presented as the linear increase in 
fibrinogen (grams per liter) per each pollut-
ant’s IQR.
Data were analyzed using the statistical 
package SAS version 9.1 (SAS Institute Inc., 
Cary, NC, USA).
Results
Study population. The study population 
consisted of 45 participants (22 males, 23 
females) with a mean of 3.9 (range, 1–6) 
repeated blood samples, mean age of 26.6 
years (range, 19–48 years), and mean BMI of 
22.7 (range, 17.8–29.9). Ten of the 45 sub-
jects had a history of well-controlled asthma.
Inflammatory markers. Table 1 displays 
summary data on the inflammatory markers 
by study and participant characteristics. A 
total of 163 samples of IL-6 and 160 samples 
of fibrinogen were available for analysis. IL-6 
and fibrinogen were moderately correlated 
(Spearman correlation coefficient = 0.21, 
p = 0.01).
Pollutant data. The mean (range) mete-
orologic and pollutant data were as follows: 
temperature, 9.2°C (–24.6 to 37.2°C); relative 
humidity, 69.6% (15–100%); O3, 21.9 ppb 
(0–136 ppb); NO2, 23.8 ppb (0–106 ppb); 
SO2, 3.5 ppb (0–70 ppb); carbon monoxide, 
0.7 ppm (0–4 ppm); and PM2.5, 8.5 µg/m3 
(0–140 µg/m3). These levels are comparable 
to those reported for major cities in Europe 
and the United States (Dubowsky et al. 2006; 
Rückerl et al. 2007). Table 2 displays the mete-
orologic and pollutant data stratified by season.
Table 3 displays correlations for the pol-
lutants and meteorologic parameters. We 
Table 1. Inflammatory markers by study and participant characteristics.
Study/characteristic
No. of 
subjects
Mean fibrinogen 
(range) (g/L)
Mean IL-6 (range) 
(pg/mL)
Study A
All participants 23 2.30 (0.97–3.80) 0.64 (0–2.67)
Female 12 2.47 (1.50–3.80) 0.50 (0.02–2.40)
Male 11 2.09 (0.97–2.93) 0.82 (0.00–2.67)
Nonasthmatic 13 2.29 (0.97–3.53) 0.75 (0.00–2.67)
Asthmatic 10 2.32 (1.38–3.80) 0.50 (0.05–1.84)
Study B
All participants 22 2.54 (1.38–4.55) 39.06 (3.97–146.20)
Female 11 2.83 (1.87–4.36) 48.93 (4.52–138.30)
Male 11 2.35 (1.38–4.55) 33.38 (3.97–146.20)
Study A analyzed IL-6 samples using ELISA plates, whereas study B used the Luminex bead assay system. IL-6 data 
were transformed to standard scores (Z-scores) before compilation into single data set. Thompson et al.
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observed significant correlations among NO2, 
SO2, CO, and PM2.5. NO2, SO2, and CO 
were negatively correlated with O3.
Regression results. IL-6 was positively cor-
related with each of the pollutants investi-
gated and reached statistical significance at 
the 95% level with O3 and SO2 (Figure 1). 
Associations increased with longer moving 
averages, with statistical significance being 
reached with the 1- to 6-day moving average 
for O3 and the 4- and 5-day moving average 
for SO2. We observed similar trends for NO2 
and PM2.5. We observed the strongest asso-
ciation between IL-6 and O3 using the 4-day 
moving average: a 0.31 SD increase in IL-6 
per O3 IQR [95% confidence interval (CI), 
0.08–0.54]. The 4-day moving average for 
SO2 showed a 0.25 SD increase in IL-6 per 
SO2 IQR (95% CI, 0.06–0.43). The positive 
association between IL-6 and each pollutant 
declined with moving averages longer than 
6 days. Fibrinogen was not significantly corre-
lated with any of the pollutants investigated, 
and we found no trend for increasing moving 
averages (Figure 2).
Effect modification by season. Pollution 
associations with level of IL-6 varied by sea-
son, with higher effects of O3 on IL-6 in 
the spring and summer and higher effects of 
PM2.5 in the summer. NO2 associations with 
IL-6 were elevated both in summer (mar-
ginally) and in winter. The significance of 
the effect modification increased with mov-
ing averages up to 3 days, with the strongest 
effects occurring using 2-day moving averages 
(Figure 3). We observed no effect modifica-
tion by season for fibrinogen and the investi-
gated pollutants.
Discussion
In measurements taken before controlled 
chamber exposure to pollution, study partici-
pants had elevated systemic levels of IL-6 in 
response to elevations in the previous 4-day 
cumulative averages of ambient O3 and SO2 
levels. IL-6 responses tended to be higher in 
the spring and summer for O3 and in the 
summer for PM2.5. In Toronto these are sea-
sons when open windows may allow more 
penetration of O3 (Ren et al. 2006; Stafoggia 
et al. 2008) and when mixtures of O3 and 
particulate pollution may be more prominent.
The observed correlations for the pol-
lutants and meteorologic parameters in this 
study (Table 3) were consistent with the pri-
mary sources of the pollutants in the study 
region and established atmospheric chemical 
processes. The negative correlation between 
O3 and NO2 is in keeping with the process of 
nitric oxide scavenging O3 in the atmosphere 
and the photodissociation of NO2 to nitric 
oxide and O3 (Beaney and Gough 2002). 
The correlation among CO, SO2, and NO2 
suggests traffic as the common source. This 
premise is also supported by the fact that the 
hour-of-day effect for each pollutant peaked 
in the mornings and, to a lesser extent, the 
afternoons and the day-of-week effect showed 
a drop on weekends.
The literature documents pollutant-
  associated elevations in pulmonary IL-6 in 
healthy subjects (in vivo) and tissue (in vitro) 
(Arsalane et al. 1995; Carter et al. 1997; 
Devlin et al. 1991; Nordenhäll et al. 2000; 
Quay et al. 1998; Rückerl et al. 2007). 
Elevations in systemic IL-6 with elevated PM 
pollution have also been found in subjects 
with preexisting chronic inflammatory condi-
tions (Dubowsky et al. 2006). Our study adds 
to the conclusion that pollution may increase 
systemic inflammation even in young healthy 
subjects. In young people, beyond the acute 
subclinical effects, recurrent low-grade acute 
inflammatory responses to pollution may ulti-
mately have implications for the evolution of 
atherosclerosis and other processes influenced 
by inflammation (Künzli et al. 2005).
Fibrinogen was not significantly associ-
ated with any of the pollutants considered 
in this investigation. It may be that ambient 
levels of PM2.5 in this study were too low 
to induce a significant effect. This hypoth-
esis is supported by the literature, which has 
reported no significant association between 
ambient pollution and fibrinogen at low levels 
of exposure (Pope et al. 2004; Rückerl et al. 
2006) but significant associations with high 
exposures such as during high air pollution 
episodes or controlled human exposure stud-
ies (Ghio et al. 2000).
In our study of young healthy subjects, we 
found that cumulative exposure to pollution 
over longer periods of time (3–6 days) was 
Table 2. Pollutant and meteorologic data by season, 14 July 1999 to 27 March 2006 (mean ± SD).
Pollutant Spring Summer Autumn Winter Annual
O3 (ppb) 26.42 ± 13.55 30.80 ± 18.76 16.89 ± 13.40 13.78 ± 9.27 21.94 ± 15.78
NO2 (ppb) 24.98 ± 13.36 20.83 ± 11.54 22.61 ± 11.19 26.78 ± 10.70 23.79 ± 11.95
SO2 (ppb) 3.09 ± 11.40 2.95 ± 13.62 3.61 ± 3.60 4.60 ± 4.67 3.57 ± 9.31
PM2.5 (µg/m3) 7.52 ± 7.29 12.34 ± 11.26 7.70 ± 8.05 6.12 ± 4.98 8.46 ± 8.57
Temperature (°C) 7.47 ± 7.86 21.11 ± 4.88 10.93 ± 7.22 –2.85 ± 6.17 9.22 ± 10.82
Humidity (%) 64.20 ± 17.83 66.69 ± 16.39 73.31 ± 15.13 74.25 ± 12.41 69.58 ± 16.16
Table 3. Meteorologic and pollutant data (daily averages): Spearman rank correlation coefficients for the 
study period 14 July 1999 to 27 March 2006.
CO NO2 O3 SO2 PM2.5 Humidity Temperature
CO 1.00 0.49 –0.24 0.43 0.25 –0.06 –0.10
NO2 1.00 –0.53 0.44 0.41 –0.11 –0.19
O3 1.00 –0.19 0.03** –0.23 0.32
SO2 1.00 0.45 –0.10 –0.09
PM2.5 1.00 0.10 0.42
Humidity 1.00 0.05
Temperature 1.00
All correlations p < 0.01 unless otherwise specified. 
**p = 0.148.
Figure 1. Associations between IL-6 and (A) O3, (B) SO2, (C) NO2, and (D) PM2.5, per IQR. All models were 
adjusted for age, sex, BMI, asthma, day of the week, season, temperature (24-hr moving average), and 
relative humidity (24-hr moving average). Data are mean changes in IL-6 SDs with 95% CIs.
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associated with the strongest associations with 
elevated IL-6. In elderly subjects with diabetes 
or obesity, longer cumulative averages also 
resulted in the greatest effects on inflamma-
tion in a study of PM2.5 effects on CRP, IL-6, 
and white blood cells (Dubowsky et al. 2006). 
Rückerl et al. (2007) found an increase in 
IL-6 associated with particle number concen-
tration, with a shorter lag of 12–17 hr. It may 
be that because all of our blood draws took 
place at 1000 hours, the 2- to 12-hr moving 
averages represent times when most subjects 
were in their homes; this may have attenuated 
the more immediate effects of outdoor pollu-
tion levels. Alternatively, at these levels of pol-
lution, a longer cumulative exposure may be 
needed for this inflammatory response.
A limitation of this study was the small 
sample size, which limited power to test for 
interactions. Additional limitations include 
the absence of indoor home monitoring and 
the use of fixed-site ambient pollution moni-
toring, which may result in exposure misclas-
sification, particularly for ambient pollutants 
that have strong local sources (Briggs et al. 
1997). Each of these limitations would be 
expected to bias the results toward the null. 
Although we found that the association of 
many of the pollutants with elevated IL-6 was 
greater in the summer, correlation among the 
pollutants and limited numbers of observa-
tions made it difficult to evaluate which of the 
pollutants, or which mixture of pollutants, 
was leading to the increased inflammatory 
response. We could not confirm the asso-
ciations of ambient pollution with inflamma-
tion by using additional complementary end 
points (e.g., CRP, tumor necrosis factor-α). 
We are able to describe relative but not abso-
lute changes of IL-6 levels in response to pol-
lution because we transformed the data to 
Z-scores in order to combine data from two 
separate studies.
The potential implications of the findings 
of this study extend beyond demonstrating 
that ambient pollutant exposure has a signifi-
cant effect on baseline systemic levels of IL-6. 
Knowledge regarding the effect of prior ambi-
ent pollution exposure in baseline evaluation 
of systemic inflammation in human chamber 
exposure studies is important for interpreta-
tion of the results of such studies. Ning et al. 
(2004), using in vitro studies, demonstrated 
that “priming” of lung epithelial cells with 
inflammatory mediators before exposure to 
fine CAPs resulted in a greater inflammatory 
response. By analogy, priming of baseline 
inflammatory status by prior ambient air pol-
lution exposure could modify the response 
of human subjects to controlled pollutant 
exposure in chamber studies. Such effect mod-
ification could lead to nondifferential misclas-
sification bias (trials are conducted in random 
order), resulting in an underestimation of the 
true effect that pollutant exposure has on the 
induction of inflammation in humans.
Alternatively, ambient pollution could 
potentially prime and amplify the response to 
exposure in the chamber. A third possibility 
is that adaptation through ambient exposures 
to pollution could dampen certain immuno-
logic or physiologic responses to acute cham-
ber exposures (Bell et al. 1977). Finally, if 
prior exposure to ambient pollution were to 
equally affect pre- and postexposure measure-
ments, then there would be much less con-
cern about taking prior exposures to ambient 
pollutants into effect when doing controlled 
exposure studies. Investigation of the effects 
of cumulative ambient exposures to pollutants 
on responses to controlled human chamber 
exposure to pollutants will help in the inter-
pretation of these studies.
Conclusion
Our results support previous findings of an 
association between ambient pollution and 
IL-6. In our analysis, exposure to ambient lev-
els of O3 and SO2 was positively and signifi-
cantly associated with a systemic inflammatory 
response as measured by systemic levels of IL-6. 
The association between IL-6 and O3 and SO2 
demonstrated a cumulative lag effect with the 
strongest effects observed using 3- to 5-day 
moving averages. Pollution effects varied by 
season. Fibrinogen levels were not correlated 
with any of the investigated pollutants. Having 
demonstrated an effect of ambient pollutant 
exposure on baseline systemic levels of IL-6, 
future research should focus on whether ambi-
ent pollution exposure modifies the effect of 
inflammatory responses to controlled pollution 
exposures human chamber studies.
Figure 2. Associations between fibrinogen (g/L) and O3 (A), SO2 (B), and NO2 (C) per 1 ppb increase, and 
PM2.5 (D) per 1 µg/m3 increase. All models were adjusted for age, sex, BMI, asthma, day of the week, 
season, temperature (24-hr moving average), and relative humidity (24-hr moving average). Data are mean 
changes in fibrinogen with 95% CIs.
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